EZH2 and mesothelioma: The distribution of EZH2 expression, survival of mesothelioma patients, and EZH2 expression are depicted in Fig. 1C. The expression of EZH2 provided a robust predictive effect on prognosis as ROC curves showed the AUC of 0.740 in EZH2 expression predicting 1-year survival, 0.756 in 2-year survival, and 0.692 in 3-year survival (Fig. 1D).